Nexalin Technology, Inc. (NASDAQ:NXL – Get Free Report)’s share price was down 3% during mid-day trading on Thursday . The stock traded as low as $0.94 and last traded at $0.96. Approximately 153,332 shares were traded during trading, a decline of 89% from the average daily volume of 1,409,454 shares. The stock had previously closed at $0.98.
Nexalin Technology Stock Up 0.9 %
The business’s fifty day moving average price is $1.31 and its 200 day moving average price is $1.11. The firm has a market capitalization of $10.20 million, a PE ratio of -1.46 and a beta of 5.69.
Institutional Investors Weigh In On Nexalin Technology
A hedge fund recently bought a new stake in Nexalin Technology stock. CVI Holdings LLC acquired a new stake in shares of Nexalin Technology, Inc. (NASDAQ:NXL – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 55,462 shares of the company’s stock, valued at approximately $94,000. CVI Holdings LLC owned 0.52% of Nexalin Technology as of its most recent SEC filing. Hedge funds and other institutional investors own 0.65% of the company’s stock.
About Nexalin Technology
Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia.
Recommended Stories
- Five stocks we like better than Nexalin Technology
- Market Cap Calculator: How to Calculate Market Cap
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- What Investors Need to Know to Beat the Market
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 8/19 – 8/23
Receive News & Ratings for Nexalin Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexalin Technology and related companies with MarketBeat.com's FREE daily email newsletter.